SPARSH BIOTECH is rapidly establishing itself as a key player in the healthcare sector, especially recognized for its innovative process of manufacturing Amoxycillin and Augmentin. The organization boasts state-of-the-art infrastructure and a focused team ensuring high-quality medications benefiting patients worldwide . V